Implementation of uHearℿ- an iOS-based application to screen for hearing loss - in older patients with cancer undergoing a comprehensive geriatric assessment

详细信息    查看全文

• 作者：Michelle Lycke^a ; Tom Boterberg^b ; Evi Martens^c ; Lore Ketelaars^c ; Hans Pottel^d ; Antoon Lambrecht^e ; Koen Van Eygen^a ; ^f ; Laurence De Coster^g ; Ingeborg Dhooge^h ; Hans Wildiersⁱ ; Philip R. Debruyne^a ; ^j ; ^k ; ^{Philip.Debruyne@azgroeninge.be" class="auth_mail" title="E-mail the corresponding author}
• 关键词：Older cancer patients ; Comprehensive geriatric assessment ; Hearing loss ; uHear&trade
• 刊名：Journal of Geriatric Oncology
• 出版年：2016
• 出版时间：March 2016
• 年：2016
• 卷：7
• 期：2
• 页码：126-133
• 全文大小：448 K

文摘

Validation of uHear™ as a screening tool to detect hearing loss in older patients with cancer without a known diagnosis of presbycusis, as part of a Comprehensive Geriatric Assessment (CGA).

Materials and Methods

Patients (≥ 70 years) with a histologically confirmed diagnosis of cancer, were enrolled at the time of CGA screening. Patients were evaluated by uHear™, which was compared to conventional audiometry as gold standard. We defined a pure-tone average (PTA) of ≥ 40 dB HL as the pass or fail screening cut-off. Validation of uHear™ was defined in terms of diagnostic accuracy through Receiver Operating Characteristics (ROC)-analysis. To accept uHear™, we estimated that the Area Under the ROC-curve (AUC) had to differ significantly from 0.50 with an AUC of at least 0.70. The Whispered Voice Test and Hearing Handicap Inventory for the Elderly were also administered.

Results

Thirty-three patients consented for participation. In one patient, the results of one ear were excluded from the analysis as the patient was documented with a known hearing disorder in that ear. Significant hearing loss, defined by a PTA of ≥ 40 dB HL calculated from the air conduction thresholds at 0.5, 1.0 and 2.0 kHz, was found in 15.4% of tested ears. uHear™ showed excellent diagnostic accuracy with an AUC ± SE of 0.98 ± 0.14. It provided maximum sensitivity (100.0%) but poor specificity (36.4%) at our predefined cut-off score of ≥ 40 dB HL.

Conclusion

uHear™ can be implemented as a screening tool to detect hearing loss in older patients with cancer within a CGA.